Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU

Megan Y. Harada, David M. Hoang, Andrea A. Zaw, Jason S. Murry, Oksana Volod, Beatrice J. Sun, Miriam A Nuno, Russell Mason, Daniel R. Margulies, Eric J. Ley

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: Recent studies reveal a high occurrence of overdiagnosis of heparin-induced thrombocytopenia in surgical patients with critical illness. The optimal criteria for diagnosis of heparin-induced thrombocytopenia remain unclear, contributing to unnecessary treatment. We reviewed patients who were admitted to surgical ICUs and were suspected of heparin-induced thrombocytopenia to identify how often patients were correctly treated. Design: In this clinical prospective study, data were collected including age, sex, antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, serotonin release assay, and Warkentin 4Ts scores. Heparin-induced thrombocytopenia-positive patients were defined as those with both positive antiplatelet factor 4/heparin enzyme-linked immunosorbent assay (optical density, ≥ 0.40) and positive serotonin release assay results. Setting: Urban tertiary medical center. Patients: Patients admitted to the surgical and cardiac ICU who were presumed to have heparin-induced thrombocytopenia and underwent antiplatelet factor 4/heparin enzyme-linked immunosorbent assay and serotonin release assay testing between January 1, 2011, and August 1, 2014. Interventions: None. Measurements and Main Results: A total of 135 patients had 4Ts, antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, and serotonin release assay scores. A total of 11 patients (8.1%) had positive serotonin release assay and 80 patients had positive antiplatelet factor 4/heparin enzyme-linked immunosorbent assay; 10 patients were identified as heparin-induced thrombocytopenia positive. Positive serotonin release assay was noted in nine of 11 patients (81.8%) with antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density greater than or equal to 2.0, compared with one of 22 patients (4.5%) with optical density values of 0.85-1.99, and one of 102 patients (1.0%) with optical density values of 0-0.84. Out of 135 patients, 29 patients (21.5%) received treatment with argatroban, lepirudin, or fondaparinux: 10 of 10 heparin-induced thrombocytopenia-positive patients (100%) compared with 19 of 125 heparin-induced thrombocytopenia-negative patients (15%). Conclusions: Overtreatment of heparin-induced thrombocytopenia in the surgical ICU continues even with recent increased caution encouraging a higher antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density threshold before initiating treatment. More stringent criteria should be used to determine when to order serologic testing and when the results of such testing should prompt a change in anticoagulant treatment. If antiplatelet factor 4/heparin enzyme-linked immunosorbent assay is used to consider immediate treatment, an optical density greater than or equal to 2.0 may be a more appropriate threshold.

Original languageEnglish (US)
Pages (from-to)28-34
Number of pages7
JournalCritical Care Medicine
Volume45
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Thrombocytopenia
Heparin
Enzyme-Linked Immunosorbent Assay
Serotonin
Medical Overuse
Therapeutics
Sex Factors
Critical Illness
Anticoagulants

Keywords

  • heparin-induced thrombocytopenia
  • platelet factor 4
  • serotonin release assay

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Harada, M. Y., Hoang, D. M., Zaw, A. A., Murry, J. S., Volod, O., Sun, B. J., ... Ley, E. J. (2017). Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU. Critical Care Medicine, 45(1), 28-34. https://doi.org/10.1097/CCM.0000000000002002

Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU. / Harada, Megan Y.; Hoang, David M.; Zaw, Andrea A.; Murry, Jason S.; Volod, Oksana; Sun, Beatrice J.; Nuno, Miriam A; Mason, Russell; Margulies, Daniel R.; Ley, Eric J.

In: Critical Care Medicine, Vol. 45, No. 1, 01.01.2017, p. 28-34.

Research output: Contribution to journalArticle

Harada, MY, Hoang, DM, Zaw, AA, Murry, JS, Volod, O, Sun, BJ, Nuno, MA, Mason, R, Margulies, DR & Ley, EJ 2017, 'Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU', Critical Care Medicine, vol. 45, no. 1, pp. 28-34. https://doi.org/10.1097/CCM.0000000000002002
Harada MY, Hoang DM, Zaw AA, Murry JS, Volod O, Sun BJ et al. Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU. Critical Care Medicine. 2017 Jan 1;45(1):28-34. https://doi.org/10.1097/CCM.0000000000002002
Harada, Megan Y. ; Hoang, David M. ; Zaw, Andrea A. ; Murry, Jason S. ; Volod, Oksana ; Sun, Beatrice J. ; Nuno, Miriam A ; Mason, Russell ; Margulies, Daniel R. ; Ley, Eric J. / Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU. In: Critical Care Medicine. 2017 ; Vol. 45, No. 1. pp. 28-34.
@article{5b4bdbe2520f454991beafee30aa8f31,
title = "Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU",
abstract = "Objective: Recent studies reveal a high occurrence of overdiagnosis of heparin-induced thrombocytopenia in surgical patients with critical illness. The optimal criteria for diagnosis of heparin-induced thrombocytopenia remain unclear, contributing to unnecessary treatment. We reviewed patients who were admitted to surgical ICUs and were suspected of heparin-induced thrombocytopenia to identify how often patients were correctly treated. Design: In this clinical prospective study, data were collected including age, sex, antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, serotonin release assay, and Warkentin 4Ts scores. Heparin-induced thrombocytopenia-positive patients were defined as those with both positive antiplatelet factor 4/heparin enzyme-linked immunosorbent assay (optical density, ≥ 0.40) and positive serotonin release assay results. Setting: Urban tertiary medical center. Patients: Patients admitted to the surgical and cardiac ICU who were presumed to have heparin-induced thrombocytopenia and underwent antiplatelet factor 4/heparin enzyme-linked immunosorbent assay and serotonin release assay testing between January 1, 2011, and August 1, 2014. Interventions: None. Measurements and Main Results: A total of 135 patients had 4Ts, antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, and serotonin release assay scores. A total of 11 patients (8.1{\%}) had positive serotonin release assay and 80 patients had positive antiplatelet factor 4/heparin enzyme-linked immunosorbent assay; 10 patients were identified as heparin-induced thrombocytopenia positive. Positive serotonin release assay was noted in nine of 11 patients (81.8{\%}) with antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density greater than or equal to 2.0, compared with one of 22 patients (4.5{\%}) with optical density values of 0.85-1.99, and one of 102 patients (1.0{\%}) with optical density values of 0-0.84. Out of 135 patients, 29 patients (21.5{\%}) received treatment with argatroban, lepirudin, or fondaparinux: 10 of 10 heparin-induced thrombocytopenia-positive patients (100{\%}) compared with 19 of 125 heparin-induced thrombocytopenia-negative patients (15{\%}). Conclusions: Overtreatment of heparin-induced thrombocytopenia in the surgical ICU continues even with recent increased caution encouraging a higher antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density threshold before initiating treatment. More stringent criteria should be used to determine when to order serologic testing and when the results of such testing should prompt a change in anticoagulant treatment. If antiplatelet factor 4/heparin enzyme-linked immunosorbent assay is used to consider immediate treatment, an optical density greater than or equal to 2.0 may be a more appropriate threshold.",
keywords = "heparin-induced thrombocytopenia, platelet factor 4, serotonin release assay",
author = "Harada, {Megan Y.} and Hoang, {David M.} and Zaw, {Andrea A.} and Murry, {Jason S.} and Oksana Volod and Sun, {Beatrice J.} and Nuno, {Miriam A} and Russell Mason and Margulies, {Daniel R.} and Ley, {Eric J.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/CCM.0000000000002002",
language = "English (US)",
volume = "45",
pages = "28--34",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU

AU - Harada, Megan Y.

AU - Hoang, David M.

AU - Zaw, Andrea A.

AU - Murry, Jason S.

AU - Volod, Oksana

AU - Sun, Beatrice J.

AU - Nuno, Miriam A

AU - Mason, Russell

AU - Margulies, Daniel R.

AU - Ley, Eric J.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective: Recent studies reveal a high occurrence of overdiagnosis of heparin-induced thrombocytopenia in surgical patients with critical illness. The optimal criteria for diagnosis of heparin-induced thrombocytopenia remain unclear, contributing to unnecessary treatment. We reviewed patients who were admitted to surgical ICUs and were suspected of heparin-induced thrombocytopenia to identify how often patients were correctly treated. Design: In this clinical prospective study, data were collected including age, sex, antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, serotonin release assay, and Warkentin 4Ts scores. Heparin-induced thrombocytopenia-positive patients were defined as those with both positive antiplatelet factor 4/heparin enzyme-linked immunosorbent assay (optical density, ≥ 0.40) and positive serotonin release assay results. Setting: Urban tertiary medical center. Patients: Patients admitted to the surgical and cardiac ICU who were presumed to have heparin-induced thrombocytopenia and underwent antiplatelet factor 4/heparin enzyme-linked immunosorbent assay and serotonin release assay testing between January 1, 2011, and August 1, 2014. Interventions: None. Measurements and Main Results: A total of 135 patients had 4Ts, antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, and serotonin release assay scores. A total of 11 patients (8.1%) had positive serotonin release assay and 80 patients had positive antiplatelet factor 4/heparin enzyme-linked immunosorbent assay; 10 patients were identified as heparin-induced thrombocytopenia positive. Positive serotonin release assay was noted in nine of 11 patients (81.8%) with antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density greater than or equal to 2.0, compared with one of 22 patients (4.5%) with optical density values of 0.85-1.99, and one of 102 patients (1.0%) with optical density values of 0-0.84. Out of 135 patients, 29 patients (21.5%) received treatment with argatroban, lepirudin, or fondaparinux: 10 of 10 heparin-induced thrombocytopenia-positive patients (100%) compared with 19 of 125 heparin-induced thrombocytopenia-negative patients (15%). Conclusions: Overtreatment of heparin-induced thrombocytopenia in the surgical ICU continues even with recent increased caution encouraging a higher antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density threshold before initiating treatment. More stringent criteria should be used to determine when to order serologic testing and when the results of such testing should prompt a change in anticoagulant treatment. If antiplatelet factor 4/heparin enzyme-linked immunosorbent assay is used to consider immediate treatment, an optical density greater than or equal to 2.0 may be a more appropriate threshold.

AB - Objective: Recent studies reveal a high occurrence of overdiagnosis of heparin-induced thrombocytopenia in surgical patients with critical illness. The optimal criteria for diagnosis of heparin-induced thrombocytopenia remain unclear, contributing to unnecessary treatment. We reviewed patients who were admitted to surgical ICUs and were suspected of heparin-induced thrombocytopenia to identify how often patients were correctly treated. Design: In this clinical prospective study, data were collected including age, sex, antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, serotonin release assay, and Warkentin 4Ts scores. Heparin-induced thrombocytopenia-positive patients were defined as those with both positive antiplatelet factor 4/heparin enzyme-linked immunosorbent assay (optical density, ≥ 0.40) and positive serotonin release assay results. Setting: Urban tertiary medical center. Patients: Patients admitted to the surgical and cardiac ICU who were presumed to have heparin-induced thrombocytopenia and underwent antiplatelet factor 4/heparin enzyme-linked immunosorbent assay and serotonin release assay testing between January 1, 2011, and August 1, 2014. Interventions: None. Measurements and Main Results: A total of 135 patients had 4Ts, antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, and serotonin release assay scores. A total of 11 patients (8.1%) had positive serotonin release assay and 80 patients had positive antiplatelet factor 4/heparin enzyme-linked immunosorbent assay; 10 patients were identified as heparin-induced thrombocytopenia positive. Positive serotonin release assay was noted in nine of 11 patients (81.8%) with antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density greater than or equal to 2.0, compared with one of 22 patients (4.5%) with optical density values of 0.85-1.99, and one of 102 patients (1.0%) with optical density values of 0-0.84. Out of 135 patients, 29 patients (21.5%) received treatment with argatroban, lepirudin, or fondaparinux: 10 of 10 heparin-induced thrombocytopenia-positive patients (100%) compared with 19 of 125 heparin-induced thrombocytopenia-negative patients (15%). Conclusions: Overtreatment of heparin-induced thrombocytopenia in the surgical ICU continues even with recent increased caution encouraging a higher antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density threshold before initiating treatment. More stringent criteria should be used to determine when to order serologic testing and when the results of such testing should prompt a change in anticoagulant treatment. If antiplatelet factor 4/heparin enzyme-linked immunosorbent assay is used to consider immediate treatment, an optical density greater than or equal to 2.0 may be a more appropriate threshold.

KW - heparin-induced thrombocytopenia

KW - platelet factor 4

KW - serotonin release assay

UR - http://www.scopus.com/inward/record.url?scp=85006412343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006412343&partnerID=8YFLogxK

U2 - 10.1097/CCM.0000000000002002

DO - 10.1097/CCM.0000000000002002

M3 - Article

VL - 45

SP - 28

EP - 34

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 1

ER -